Global Postherpetic Neuralgia Market accounted for US$ 665.84 million in 2020 and is estimated to be US$ 1128.81 million by 2030 and is anticipated to register a CAGR of 5.30%. Postherpetic neuralgia (PHN) is a type of nerve pain produced by the reactivation of the varicella zoster virus, which causes damage to a peripheral nerve (shingles). PHN is nerve pain that lasts longer than 30 days after herpes zoster reactivation. Damage to the peripheral nerve is the cause of the nerve pain. Postherpetic neuralgia (PHN) is a type of neuropathic pain that is caused by an injury. In many situations, the recurrence of the varicella zoster virus causes harm to the peripheral nerves. Herpes zoster, also known as shingles, is caused by the virus. Neuralgia is more common in places with only one sensory nerve. The pain from post-herpetic neuralgia can continue up to 85 days. In addition to PHN, a person may have a variety of additional health problems. Itching, strange sensations, pain from gentle contact, hyperalgesia, and so on. Intermittent or continuous nerve pain in a previously shingles-affected location is the most common sign of post-herpetic neuralgia.

The report " Global Postherpetic Neuralgia Market, By Type (Patches, Drugs, and Opioids), By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Highlights:

In 2021, Acasti Pharma Inc. ("Acasti" or the "Company") (Nasdaq: ACST and TSX-V: ACST) announced the start of a planned pharmacokinetic (PK) bridging study in 50 healthy people to assess the relative bioavailability of intravenous (IV) GTX-104 to already marketed oral nimodipine capsules. The next stage in the proposed 505(b)(2) regulatory process for GTX-104 is a PK study.
In 2021, In the United Kingdom, GlaxoSmithKline plc (GSK) launched the Shingrix vaccination, which helps prevent people from shingles. The vaccine, which also protects against post-herpetic neuralgia (PHN), a common consequence of shingles, is approved for adults aged 18 and above who are at a higher risk of developing shingles.
Analyst View:

The rising occurrence of fungal diseases around the world is fueling the market's expansion. Furthermore, increased use of immunosuppressive and antineoplastic drugs, prosthetic devices and grafts, and broad-spectrum antibiotics has led in an upsurge in fungal infections in recent years. According to statistics provided by the Centers for Disease Control and Prevention in 2017, over 220,000 new people are infected with cryptococcal meningitis each year, which is a brain infection that causes 181,000 deaths each year around the world. Because of the high incidence of HIV/AIDS in Sub-Saharan Africa, the majority of the deaths were reported there. Due to the significant prevalence of mycological diseases over the world, this indicates a potential market for antifungal medications. The expansion in the global geriatric population is projected to increase demand for antifungals to treat opportunistic fungal infections, as older people are more susceptible to infectious diseases and chronic disorders, such as HIV and cancer. The demand for fungistatic drugs is expected to continue robust through 2025, owing to an increase in cases of difficult-to-diagnose fungal infections that result in high mortality and morbidity rates.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Postherpetic Neuralgia Market, By Type (Patches, Drugs, and Opioids), By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”
To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Posthe...

Key Market Insights from the report:

The Global Postherpetic Neuralgia Market accounted for US$ 665.84 million in 2020 and is estimated to be US$ 1128.81 million by 2030 and is anticipated to register a CAGR of 5.30%. The global post herpetic neuralgia treatment market can be segmented based on type, distribution channel, and region.

Based on Type, Global Postherpetic Neuralgia Market is segmented into Patches, Drugs, and Opioids.
Based on Distribution Channel, Global Postherpetic Neuralgia Market is segmented into Hospital Pharmacies, Drug Stores, Retail Pharmacies, and Others.
By Region, the Global Postherpetic Neuralgia Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape & their strategies of Global Postherpetic Neuralgia Market:

Some of the key players operating in the global post herpetic neuralgia treatment market are Pfizer Inc, Teikoku Pharma USA, Inc., Janssen Pharmaceuticals, Inc., Teva Pharmaceuticals Ltd, and Endo Pharmaceuticals Inc..

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
To know more

Contact Us:

Sales

Prophecy Market Insights

1 860 531 2701

Email- [email protected]

Website- www.prophecymarketinsights.com